HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Endocrine Cancers and Oncology

The study of endocrine cancers and oncology focuses on tumors affecting hormone-producing glands such as the thyroid, pancreas, and adrenal glands. Malignancies like pancreatic neuroendocrine tumors and medullary thyroid carcinoma require specialized treatment approaches due to their complex interaction with hormonal regulation. Advances in molecular oncology have led to targeted therapies that inhibit abnormal signaling pathways, improving survival rates. Immunotherapy is also gaining traction as a promising approach for endocrine cancers, particularly in cases resistant to traditional chemotherapy. Early detection through biomarker screening and imaging technologies enhances treatment efficacy. Ongoing research continues to refine therapeutic options, providing hope for improved patient outcomes.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp